Microsoft (MSFT) slumps after so-so Q3 earnings >>> READ MORE


19 Biotechnology Stocks to Sell Now

This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

How to Play a Down and Out Amgen, Inc. (AMGN) Stock

Biotech stocks suffered during Monday's downdraft. With leaders like Amgen (AMGN) now trending lower, the time for bear plays is at hand. More 

Trade of the Day: Celgene Corporation (CELG) Looking Healthy Again

Despite industry headwinds in the form of overpricing concerns, CELG stock still looks strong and should rise another 14%. More 

Why Celgene Corporation (CELG) Can Finish 2016 in the Black

With Celgene's increased guidance and a strong pipeline, CELG stock looks undervalued at current prices. More 

Celgene Corporation (CELG) – Two Ways to Trade CELG Stock

CELG stock now sits at a critical technical juncture with two paths to take after Celgene experienced a wild ride in late July and August. More 

Gilead Sciences, Inc.: A Breakdown Looms for GILD Stock

Gilead Sciences is sitting out the biotech stock rally. In fact, an ugly breakdown looms for the ailing drug stock. Buy GILD stock puts. More 

Celgene Corporation: Why CELG Stock Could Top $200/Share

CELG stock's upside between now and the next 10 years make Celgene one of the best investments in the market. More